Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
Background Neurocysticercosis, infection of the brain with larvae of Taenia solium (pork tapeworm), is one of several forms of human cysticercosis caused by this organism. We investigated the role of albendazole and praziquantel in the treatment of patients with parenchymal neurocysticercosis by per...
Published in: | PLoS Neglected Tropical Diseases |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008
|
Subjects: | |
Online Access: | https://doi.org/10.1371/journal.pntd.0000194 https://doaj.org/article/1b326de659bb4ea1946d919a2b1b66ef |
id |
ftdoajarticles:oai:doaj.org/article:1b326de659bb4ea1946d919a2b1b66ef |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:1b326de659bb4ea1946d919a2b1b66ef 2023-05-15T15:13:53+02:00 Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. Dimitrios K Matthaiou Georgios Panos Eleni S Adamidi Matthew E Falagas 2008-03-01T00:00:00Z https://doi.org/10.1371/journal.pntd.0000194 https://doaj.org/article/1b326de659bb4ea1946d919a2b1b66ef EN eng Public Library of Science (PLoS) https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18335068/?tool=EBI https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0000194 https://doaj.org/article/1b326de659bb4ea1946d919a2b1b66ef PLoS Neglected Tropical Diseases, Vol 2, Iss 3, p e194 (2008) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2008 ftdoajarticles https://doi.org/10.1371/journal.pntd.0000194 2022-12-31T05:20:32Z Background Neurocysticercosis, infection of the brain with larvae of Taenia solium (pork tapeworm), is one of several forms of human cysticercosis caused by this organism. We investigated the role of albendazole and praziquantel in the treatment of patients with parenchymal neurocysticercosis by performing a meta-analysis of comparative trials of their effectiveness and safety. Methods and principal findings We performed a search in the PubMed database, Cochrane Database of Controlled Trials, and in references of relevant articles. Six studies were included in the meta-analysis. Albendazole was associated with better control of seizures than praziquantel in the pooled data analysis, when the generic inverse variance method was used to combine the incidence of seizure control in the included trials (patients without seizures/[patients x years at risk]) (156 patients in 4 studies, point effect estimate [incidence rate ratio] = 4.94, 95% confidence interval 2.45-9.98). In addition, albendazole was associated with better effectiveness than praziquantel in the total disappearance of cysts (335 patients in 6 studies, random effects model, OR = 2.30, 95% CI 1.06-5.00). There was no difference between albendazole and praziquantel in reduction of cysts, proportion of patients with adverse events, and development of intracranial hypertension due to the administered therapy. Conclusions A critical review of the available data from comparative trials suggests that albendazole is more effective than praziquantel regarding clinically important outcomes in patients with neurocysticercosis. Nevertheless, given the relative scarcity of trials, more comparative interventional studies--especially randomized controlled trials--are required to draw a safe conclusion about the best regimen for the treatment of patients with parenchymal neurocysticercosis. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic PLoS Neglected Tropical Diseases 2 3 e194 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Dimitrios K Matthaiou Georgios Panos Eleni S Adamidi Matthew E Falagas Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. |
topic_facet |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
Background Neurocysticercosis, infection of the brain with larvae of Taenia solium (pork tapeworm), is one of several forms of human cysticercosis caused by this organism. We investigated the role of albendazole and praziquantel in the treatment of patients with parenchymal neurocysticercosis by performing a meta-analysis of comparative trials of their effectiveness and safety. Methods and principal findings We performed a search in the PubMed database, Cochrane Database of Controlled Trials, and in references of relevant articles. Six studies were included in the meta-analysis. Albendazole was associated with better control of seizures than praziquantel in the pooled data analysis, when the generic inverse variance method was used to combine the incidence of seizure control in the included trials (patients without seizures/[patients x years at risk]) (156 patients in 4 studies, point effect estimate [incidence rate ratio] = 4.94, 95% confidence interval 2.45-9.98). In addition, albendazole was associated with better effectiveness than praziquantel in the total disappearance of cysts (335 patients in 6 studies, random effects model, OR = 2.30, 95% CI 1.06-5.00). There was no difference between albendazole and praziquantel in reduction of cysts, proportion of patients with adverse events, and development of intracranial hypertension due to the administered therapy. Conclusions A critical review of the available data from comparative trials suggests that albendazole is more effective than praziquantel regarding clinically important outcomes in patients with neurocysticercosis. Nevertheless, given the relative scarcity of trials, more comparative interventional studies--especially randomized controlled trials--are required to draw a safe conclusion about the best regimen for the treatment of patients with parenchymal neurocysticercosis. |
format |
Article in Journal/Newspaper |
author |
Dimitrios K Matthaiou Georgios Panos Eleni S Adamidi Matthew E Falagas |
author_facet |
Dimitrios K Matthaiou Georgios Panos Eleni S Adamidi Matthew E Falagas |
author_sort |
Dimitrios K Matthaiou |
title |
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. |
title_short |
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. |
title_full |
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. |
title_fullStr |
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. |
title_full_unstemmed |
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. |
title_sort |
albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2008 |
url |
https://doi.org/10.1371/journal.pntd.0000194 https://doaj.org/article/1b326de659bb4ea1946d919a2b1b66ef |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
PLoS Neglected Tropical Diseases, Vol 2, Iss 3, p e194 (2008) |
op_relation |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18335068/?tool=EBI https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0000194 https://doaj.org/article/1b326de659bb4ea1946d919a2b1b66ef |
op_doi |
https://doi.org/10.1371/journal.pntd.0000194 |
container_title |
PLoS Neglected Tropical Diseases |
container_volume |
2 |
container_issue |
3 |
container_start_page |
e194 |
_version_ |
1766344396764086272 |